Browsing: Cutaneous

A retrospective cohort suggests, for localized indolent mycosis fungoides, 8 Gy × 1 provides 6-month responses similar to 4 Gy…

A VA analysis of more than 33,000 high-risk patients with prior keratinocyte carcinoma reports oral nicotinamide prevented an estimated 624…

The LUCNAS trial demonstrated strikingly higher sensitivity with contrasted CT (55%) or ultrasound (64%) staging compared with clinical palpation alone…

While early salvage immunotherapy remains an attractive approach for resected high-risk melanoma, a secondary analysis of a phase 3 trial…

A single-center retrospective cohort (n=86) demonstrates sentinel node biopsy for Merkel cell carcinoma of the head and neck can identify…

Top Line: After nearly a decade of follow-up, does adjuvant nivolumab still beat ipilimumab for resected high-risk melanoma?The Study: Today…

When an option for ultra-hypofractionation makes or breaks a patient’s decision to receive treatment, it’s nice to know this retrospective…

A large multicenter prospective blinded MERLIN study enrolled 1761 patients undergoing resection of melanoma with sentinel node biopsy performed per…

A calculator risk-based skin cancer surveillance program for solid organ transplant recipients (1) confirmed a nearly eight-fold higher risk of…

A robust retrospective VA study further supports the use of the over-the-counter vitamin B3 derivative nicotinamide as non-melanoma skin cancer…